Dr. Mark J. Holterman is a physician who wears many hats: Pediatric surgeon, professor, CEO of an investment firm, as well as medical researcher/analyst, to name a few. His passion for advancement in medicine is evidenced by his dedication to research projects as well as funding and promoting medically innovative businesses (Ideamensch). He has over 30 years of experience as a physician, of which include serving as a professor and active participant in multiple medical professional organizations.
As co-founder and first CEO of the non-profit organization Alliance for the Advancement of Cellular Therapies (AACT), Dr. Mark J. Holterman is committed to the advancement of cellular therapy (CT), which promotes the ethical and safe advancement of stem cell therapy and regenerative medicine. CT involves the transplantation of human cells in order to boost the body’s disease-fighting capacity in addition to the restoration of cells and tissues. This process is used for multiple conditions including but not limited to osteoarthritis and the accompanying joint pain, alopecia (hair loss), psoriasis, and a multitude of autoimmune disorders. The ethicality of the AACT systems is a non-issue as only adult, rather than embryonic, stem cells are utilized.
Dr. Mark Holterman also supports the International Pediatric Specialists Alliance for the Children of Vietnam (IPSAC-VN). The IPSAC-VN’s purpose is sustainably improving the field of pediatric medicine for Vietnamese children. It runs multiple initiatives which supply medical staff and supplies, in addition to any necessary resources for the area.
One of many of Dr. Mark Holterman’s many passions is CellR4 – the official journal of the Cure Alliance. This publication concentrates on the repair, regeneration, differentiation, and reprogramming of cells. This journal enables the discussion of the hurdles as well as opportunities in producing new treatment options. Their publications are available at no cost on their website.
Mark J. Holterman is a physician driven by his passions in medical research and advancement. He is clearly an asset to the medical field, as evidenced by his professional accomplishments.